Scientists probe vaccine shield for vulnerable kids
NCT ID NCT05164016
Summary
This study aims to learn how well COVID-19 vaccines protect children and young adults under 24 who have cancer or have received a transplant or cellular therapy. Researchers will measure the strength and duration of the immune response in these vulnerable patients by taking small blood samples before and after vaccination. The goal is to gather knowledge to better protect immunocompromised young people.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Le Bonheur
Memphis, Tennessee, 38103, United States
-
LeBonheur
Memphis, Tennessee, 38103, United States
-
St. Jude Children's Research Hospital
Memphis, Tennessee, 38105, United States
Conditions
Explore the condition pages connected to this study.